Global Live Attenuated Vaccines for Pets Market Growth 2025-2031

The global Live Attenuated Vaccines for Pets market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Live attenuated vaccines are vaccines made from killed pathogens.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 378%.

LP Information, Inc. (LPI) ' newest research report, the “Live Attenuated Vaccines for Pets Industry Forecast” looks at past sales and reviews total world Live Attenuated Vaccines for Pets sales in 2024, providing a comprehensive analysis by region and market sector of projected Live Attenuated Vaccines for Pets sales for 2025 through 2031. With Live Attenuated Vaccines for Pets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Vaccines for Pets industry.

This Insight Report provides a comprehensive analysis of the global Live Attenuated Vaccines for Pets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Vaccines for Pets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Live Attenuated Vaccines for Pets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Vaccines for Pets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Vaccines for Pets.

This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Vaccines for Pets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine

Segmentation by Application:
Dog
Cat
Dird
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Live Attenuated Vaccines for Pets market?

What factors are driving Live Attenuated Vaccines for Pets market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Live Attenuated Vaccines for Pets market opportunities vary by end market size?

How does Live Attenuated Vaccines for Pets break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.